Startup Dossier
Tolergyx
Tolergyx develops oral immunotherapy solutions for peanut allergies, leveraging its GIDOIT® technology to deliver allergens directly to the intestine, aiming to improve tolerance, safety, and patient adherence compared to traditional oral approaches.
active
Typestartup
SectorBioTech
LocationClermont-Ferrand
About
Tolergyx develops oral immunotherapy solutions for peanut allergies, leveraging its GIDOIT® technology to deliver allergens directly to the intestine, aiming to improve tolerance, safety, and patient adherence compared to traditional oral approaches.
Structural DNA
Legal Name
Tolergyx
SIREN
999106412
Funding Lineage
Seed
Business Angels (Lead)
€3.0M
Apr 2026